Beta-Caryophyllene: The Cannabis Terpene That Could Help Treat Liver Disease | Research

The takeaway

Beta-caryophyllene, a terpene found in cannabis and many spices, shows consistent hepatoprotective effects in preclinical studies by activating CB2 receptors to reduce inflammation, fibrosis, and fat accumulation in the liver.

Liver disease patients, gastroenterologists, nutraceutical researchers, and anyone interested in terpene therapeutics

What the researchers found

β-caryophyllene acts as a dietary cannabinoid through CB2 receptor activation plus PPAR and AMPK signaling, consistently reducing hepatic steatosis, collagen deposition, and inflammatory markers across multiple liver disease models.

Why it matters

Liver disease is a growing global health burden with limited treatment options — a naturally occurring, food-safe compound that targets multiple liver damage pathways could be transformative.

The numbers in context

β-caryophyllene activates CB2 receptors plus PPAR nuclear receptor and AMPK signaling; demonstrated effects across MAFLD, alcoholic liver disease, and liver fibrosis models.

How the study worked

Systematic review compiling and critically analyzing in vitro and in vivo studies on β-caryophyllene in nonalcoholic fatty liver disease (MAFLD), alcoholic liver disease, and liver fibrosis.

What this study cannot tell us

Evidence is entirely preclinical; no human clinical trials; doses used in animal studies may not translate directly to human supplementation; regulatory pathway unclear.

How to read the evidence

Comprehensive systematic review of robust preclinical evidence, but complete absence of clinical trials limits evidence grade.

When this study was published

Published in 2026 in FASEB Journal, reflecting the growing scientific interest in dietary cannabinoids.

The bigger picture

As a GRAS (generally recognized as safe) compound already present in food, β-caryophyllene could move to clinical trials faster than novel pharmaceuticals — if regulatory and clinical validation challenges are met.

Questions still open

What oral dose of β-caryophyllene would achieve therapeutic liver concentrations in humans? Could it complement existing liver disease treatments?

Common questions

What is beta-caryophyllene?

It's a terpene found in cannabis, black pepper, cloves, and many spices. It's unique because it directly activates the CB2 cannabinoid receptor, earning it the classification of 'dietary cannabinoid.'

Can beta-caryophyllene help with liver disease?

Preclinical studies consistently show it reduces liver inflammation, fat accumulation, and fibrosis through multiple pathways. However, no human clinical trials have been conducted yet.

Read the original research

Pharmacological, Molecular Mechanisms, and Therapeutic Potential of β-Caryophyllene and β-Caryophyllene-Rich Plants in Liver Diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(1), e71344

View on PubMed ↗Publisher’s paper ↗

Citation

Bader Eddin, Lujain; Subramanya, Sandeep B; Ojha, Shreesh. (2026). Pharmacological, Molecular Mechanisms, and Therapeutic Potential of β-Caryophyllene and β-Caryophyllene-Rich Plants in Liver Diseases.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(1), e71344. https://doi.org/10.1096/fj.202502436R